NYSE ARCA | ETF
The fund invests primarily in equity securities, principally common and preferred stocks of companies of any market capitalization.
Under normal market conditions, the fund invests at least 80% of its net assets, plus borrowings for investment purposes, in securities of companies principally engaged in the research, development, production, or distribution of products and services related to the health care industry ("health care companies").
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ASND | Ascendis Pharma AS | Healthcare | Biotechnology | 17.66% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 14.66% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 6.56% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 6.00% |
| MASI | Masimo Corporation | Healthcare | Medical Devices | 4.31% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 3.65% |
| SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 3.55% |
| DXCM | DexCom Inc | Healthcare | Medical Devices | 3.32% |
| ICLR | ICON PLC | Healthcare | Diagnostics & Research | 3.31% |
| WGS | GeneDx Holdings Corp. | Healthcare | Diagnostics & Research | 3.06% |
| RYTM | Rhythm Pharmaceuticals Inc | Healthcare | Biotechnology | 3.04% |
| HUM | Humana Inc | Healthcare | Healthcare Plans | 2.87% |
| SLNO | Soleno Therapeutics Inc | Healthcare | Biotechnology | 2.45% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.43% |
| 6XC | SOLENO THERAPEUT. DL-001 | Healthcare | Biotechnology | 2.39% |
| CVS | CVS Health Corp | Healthcare | Healthcare Plans | 2.32% |
| MRUS | Merus BV | Healthcare | Biotechnology | 2.25% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.25% |
| LNTH | Lantheus Holdings Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.20% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 2.18% |